Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1Suspended 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 8Vincristine 7Prednisone 6Specimen Handling 5Rituximab 5Doxorubicin 5zanubrutinib 3prednylidene 3deltacortene 3Magnetic Resonance Spectroscopy 3tazemetostat 2fludarabine phosphate 2fludarabine 2Radiotherapy, Intensity-Modulated 2Melphalan 2Etoposide 2Drug Therapy 2CT-P10 2Biopsy 2Azacitidine 2Antibodies, Monoclonal 2vactosertib 1tisagenlecleucel 1sargramostim 1ponatinib 1pembrolizumab 1obinutuzumab 1mogamulizumab 1glucarpidase 1duvelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × E7777 fusion protein × Lymphoid × Clear all
NCT04855253 2026-01-15

Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL

Masonic Cancer Center, University of Minnesota

Phase 1/2 Suspended
30 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡